Lung Cancer Patient Survival by Treatment Type

9.5 KB of tabular data compares median survival outcomes for lung cancer patients receiving triple therapy, platinum-based doublet chemotherapy with or without concurrent radiation, and single drug treatment. The dataset was authored by Tarza Jamal Siahmansur and last updated on April 9, 2026.

Use Cases

• Compare median survival outcomes based on treatment regimen
• Analyze the relative effectiveness of triple therapy versus doublet chemotherapy
• Evaluate the impact of concurrent radiation on platinum-based chemotherapy outcomes
• Benchmark single drug treatment performance against multi-drug therapies

Strengths

• Data is structured in an Excel (XLS) format, likely facilitating direct analysis
• Dataset is licensed under CC-BY-4.0, allowing for open reuse

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download

Provenance

Source

figshare

Freshness

Last updated 2026-04-09 17:41:01; freshness should be verified